Policy briefs launched by National Cancer Society Malaysia and Boehringer Ingelheim highlights significant rates of co-existing cardiovascular, kidney, and metabolic diseases among Malaysians.
NKF and NCSM warn that cuts to the government's health budget may hit dialysis and cancer services. NKF, which receives substantial subsidies from MOH for kidney replacement therapy, says it may be forced to reduce screening and prevention programmes.
To address a shortage of dialysis products, NKF moots reducing dialysis frequency. Maaedicare and Socso are monitoring stock levels. A nephrologist urges MOH to form a nephrology task force and activate a central command structure to control distribution.
Malaysia is facing an emerging shortage of dialysers (artificial kidney) and canister/bottle packaging for haemodialysis (HD) concentrate solution. A dialyser is necessary for HD. Nephrologists say kidney failure patients can't survive without dialysis.
Chronic kidney disease is becoming one of Malaysia’s most pressing public health challenges, yet it often develops quietly and goes unnoticed until it reaches an advanced stage.
Dr Dzul says end-stage kidney disease patients may wait 2-3 years, or up to nearly 4 years, for a government haemodialysis slot as diagnosis and surgery add months, versus private centres that offer placement within 2-4 weeks after funding approval.
Maaedicare Charitable Foundation is tackling the kidney failure crisis by subsidising dialysis treatment for 100 new, low-income Malaysian patients from B40 households.
Experts warn of the increasing risk of cardiorenal metabolic (CRM) syndrome in Malaysia, a constellation of heart/kidney/metabolic conditions that has a compounded effect on patients. Malaysians face a "perfect storm" of genetic, lifestyle, dietary risks.
Patients say peritoneal dialysis is more flexible than haemodialysis, but more financial and caregiver support is needed. “Socso covers my machine and solutions, but everything else is on me,” says a PD patient who pays up to RM250 monthly out of pocket.
Health deputy DG Nor Azimi sounds the alarm on the unstoppable rise of kidney disease in Malaysia, saying public and private sectors can't keep building new dialysis centres. Peritoneal dialysis must be championed as the first-line treatment instead of HD.